Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters
- PMID: 18536655
- DOI: 10.1038/modpathol.2008.90
Expression of basal keratins and vimentin in breast cancers of young women correlates with adverse pathologic parameters
Abstract
Previous studies have suggested that breast cancer in young women has more aggressive biological features and poorer prognosis. However, the role of biological markers in these patients is not well understood. We aimed to learn more about this disease in a cohort of 125 young women from Singapore, Japan and Hong Kong, aged 35 years or less, with invasive breast cancer by evaluating the expression of vimentin and the basal cytokeratins CK14, CK5/6 and 34 beta E12. Both standard paraffin sections and tissue microarrays were used in the immunohistochemical evaluation of expression patterns of these four biological markers. CK5/6, CK14, vimentin and 34 beta E12, in increasing order of proportion, were detected in invasive carcinomas. Basal cytokeratins and vimentin showed significant inverse relationship with estrogen and progesterone receptor status while CK14 expression was found to be directly associated with c-erbB2 status. Basal cytokeratins and vimentin immunoreactivities were directly associated with CD117 and EGFR expression. Vimentin and 34 beta E12 immunopositivity correlated with tumor size, while vimentin was associated with higher histological grade. Our findings are in concert with reports that expression of basal cytokeratins and vimentin is correlated with adverse pathological parameters.
Similar articles
-
Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas.Hum Pathol. 2008 Dec;39(12):1809-15. doi: 10.1016/j.humpath.2008.05.010. Epub 2008 Aug 19. Hum Pathol. 2008. PMID: 18715613
-
Fragile histidine triad protein, WW domain-containing oxidoreductase protein Wwox, and activator protein 2gamma expression levels correlate with basal phenotype in breast cancer.Cancer. 2009 Feb 15;115(4):899-908. doi: 10.1002/cncr.24103. Cancer. 2009. PMID: 19130459 Free PMC article.
-
Immunohistochemical profile of breast cancer patients at a tertiary care hospital in South India.Asian Pac J Cancer Prev. 2011;12(3):625-9. Asian Pac J Cancer Prev. 2011. PMID: 21627355
-
Triple-negative breast cancer: current state of the art.Tumori. 2010 Nov-Dec;96(6):875-88. Tumori. 2010. PMID: 21388048 Review.
-
Om.breast cancer in very young women aged 25 year-old or below in the center of Tunisia and review of the literature.Pathol Oncol Res. 2015 Jul;21(3):553-61. doi: 10.1007/s12253-015-9944-5. Epub 2015 May 12. Pathol Oncol Res. 2015. PMID: 25962349 Review.
Cited by
-
Prioritizing drug targets by perturbing biological network response functions.PLoS Comput Biol. 2024 Jun 27;20(6):e1012195. doi: 10.1371/journal.pcbi.1012195. eCollection 2024 Jun. PLoS Comput Biol. 2024. PMID: 38935814 Free PMC article.
-
Does vimentin help to delineate the so-called 'basal type breast cancer'?J Exp Clin Cancer Res. 2009 Aug 20;28(1):118. doi: 10.1186/1756-9966-28-118. J Exp Clin Cancer Res. 2009. PMID: 19695088 Free PMC article.
-
Expression of 34βE12 may be an independent predictor of survival in breast cancer.J Int Med Res. 2021 Oct;49(10):300060520967774. doi: 10.1177/0300060520967774. J Int Med Res. 2021. PMID: 34666529 Free PMC article.
-
Suppressive impact of metronomic chemotherapy using UFT and/or cyclophosphamide on mediators of breast cancer dissemination and invasion.PLoS One. 2019 Sep 19;14(9):e0222580. doi: 10.1371/journal.pone.0222580. eCollection 2019. PLoS One. 2019. PMID: 31536574 Free PMC article.
-
Identification and Pharmacological Targeting of Treatment-Resistant, Stem-like Breast Cancer Cells for Combination Therapy.bioRxiv [Preprint]. 2025 Feb 12:2023.11.08.562798. doi: 10.1101/2023.11.08.562798. bioRxiv. 2025. PMID: 38798673 Free PMC article. Preprint.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous